Gastrointestinal System Practice Questions

Q: Which hormone influences the gastric phase of gastric acid secretion?

Gastrin. ### Explanation Gastric acid secretion occurs in three distinct phases: **Cephalic** (anticipation/smell), **Gastric** (food in the stomach), and **Intestinal** (chyme in the duodenum). **Why Gastrin is Correct:** The **Gastric Phase** accounts for approximately 60% of the total acid response to a meal. It is triggered by gastric distension and the presence of amino acids/peptides. These stimuli activate local vagovagal reflexes and stimulate **G-cells** in the antrum to release **Gastrin**. Gastrin then travels through the blood to stimulate Parietal cells (directly) and Enterochromaffin-like (ECL) cells (to release histamine), both of which increase HCL secretion. **Why Incorrect Options are Wrong:** * **Secretin (A):** Produced by S-cells in the duodenum in response to low pH. It **inhibits** gastric acid secretion and stimulates pancreatic bicarbonate secretion (the "nature's antacid"). * **VIP (B):** A neuropeptide that induces vasodilation and relaxation of GI smooth muscle. It generally inhibits gastric acid secretion. * **GIP (C):** Also known as Glucose-dependent Insulinotropic Peptide. It is an enterogastrone that inhibits gastric motility and acid secretion while stimulating insulin release. **NEET-PG High-Yield Pearls:** * **Potency:** Gastrin is the most potent stimulator of the gastric phase. * **Inhibition:** When luminal pH falls below 1.5–2.0, **Somatostatin** is released from D-cells to inhibit Gastrin release (negative feedback). * **Vagal Influence:** The Vagus nerve stimulates G-cells via **Gastrin-Releasing Peptide (GRP)**; notably, atropine does *not* block this specific pathway. * **Marker:** Serum Gastrin levels are significantly elevated in **Zollinger-Ellison Syndrome** (Gastrinoma).

Q: What is the primary action of Nitric oxide (NO) in the gastrointestinal tract?

Gastrointestinal smooth muscle relaxation. **Explanation:** **Nitric Oxide (NO)** is the primary **non-adrenergic, non-cholinergic (NANC)** inhibitory neurotransmitter in the gastrointestinal tract. It is synthesized from L-arginine by the enzyme Nitric Oxide Synthase (NOS), located in the inhibitory motor neurons of the myenteric (Auerbach’s) plexus. **Why Option C is Correct:** When NO is released, it diffuses into the smooth muscle cells and activates **soluble guanylyl cyclase**, leading to an increase in intracellular **cyclic GMP (cGMP)**. This triggers a cascade that results in the dephosphorylation of myosin light chains and the sequestration of calcium, ultimately causing **smooth muscle relaxation**. This mechanism is crucial for processes like receptive relaxation of the stomach and the relaxation of sphincters (e.g., Lower Esophageal Sphincter) during bolus transit. **Why Other Options are Incorrect:** * **Option A & B:** While NO is a potent vasodilator in the vascular system, the question asks for its **primary action within the GI tract** context. In the gut, its functional role as a neurotransmitter for motility is the physiological priority. * **Option D:** NO is inhibitory; therefore, it opposes contraction. Contraction is primarily mediated by Acetylcholine (ACh) and Substance P. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia:** Caused by the loss of NO-producing neurons in the myenteric plexus, leading to the failure of the Lower Esophageal Sphincter (LES) to relax. * **Hirschsprung Disease:** Characterized by a lack of ganglionic cells (and thus NO) in the distal colon, resulting in a tonic contraction of the segment and proximal megacolon. * **Other NANC Inhibitors:** Vasoactive Intestinal Peptide (VIP) often works synergistically with NO to induce relaxation.

Q: Gastrin is produced by:

All. **Explanation:** Gastrin is a key gastrointestinal hormone primarily known for stimulating gastric acid secretion. While its most famous site of synthesis is the stomach, it is produced in several distinct locations throughout the body, making "All" the correct answer. 1. **Gastric Antral Cells (G-cells):** This is the primary site of production. G-cells located in the antrum of the stomach secrete gastrin in response to stomach distension, proteins (amino acids), and vagal stimulation (via Gastrin-Releasing Peptide). 2. **Pancreas:** During fetal development, the pancreatic islets produce significant amounts of gastrin. In adults, while secretion is minimal under physiological conditions, the pancreas remains a potential site of synthesis (and is the most common site for gastrinomas in Zollinger-Ellison Syndrome). 3. **Pituitary Gland:** Small amounts of gastrin are synthesized in the anterior pituitary gland. It is also found in the hypothalamus and certain neurons of the vagus nerve, where it acts as a neuropeptide. **High-Yield NEET-PG Pearls:** * **Major Stimulus:** Phenylalanine and tryptophan are the most potent amino acid stimulators of gastrin. * **Inhibition:** Gastrin secretion is inhibited when luminal pH falls below 1.5 (negative feedback) and by the hormone **Somatostatin**. * **Zollinger-Ellison Syndrome (ZES):** Characterized by a gastrin-secreting tumor (gastrinoma), typically in the "Gastrinoma Triangle" (confluence of cystic/common bile duct, junction of 2nd/3rd part of duodenum, and neck/body of pancreas). * **Trophic Effect:** Beyond acid secretion, gastrin stimulates the growth of gastric mucosa; chronic hypergastrinemia leads to mucosal hyperplasia.

Q: Which of the following stimulates HCl secretion?

Somatostatin. **Explanation:** The regulation of gastric acid (HCl) secretion is a high-yield topic in GI physiology. HCl is secreted by the **parietal cells** of the stomach, primarily regulated by three stimulatory pathways and several inhibitory pathways. **Why Somatostatin is the Correct Answer (Inhibitor):** *Note: There appears to be a discrepancy in the provided key. In standard physiology, **Somatostatin is a potent inhibitor** of HCl secretion, not a stimulant. If the question asks for a stimulant, the correct answers would be Histamine or Gastrin. However, if the question asks for an inhibitor, Somatostatin is the answer.* Somatostatin acts via paracrine signaling to inhibit acid secretion through two mechanisms: 1. **Direct:** Binding to receptors on parietal cells to inhibit adenylate cyclase. 2. **Indirect:** Inhibiting the release of Gastrin (from G cells) and Histamine (from ECL cells). **Analysis of Other Options:** * **Histamine (Stimulant):** Released by Enterochromaffin-like (ECL) cells. It binds to **H2 receptors** on parietal cells, increasing cAMP to stimulate HCl secretion. * **Gastrin (Stimulant):** Secreted by G cells in the antrum. It stimulates parietal cells directly and indirectly (by triggering histamine release) via **CCK-B receptors**. * **Secretin (Inhibitor):** Released by S cells of the duodenum in response to H+. It inhibits gastric acid secretion and stimulates pancreatic bicarbonate secretion. **NEET-PG High-Yield Pearls:** * **The "Big Three" Stimulants:** Acetylcholine (Vagus/M3), Gastrin (CCK-B), and Histamine (H2). * **Potentiation:** The combined effect of these three stimulants is greater than the sum of their individual effects. * **Proton Pump:** The final common pathway for all stimulants is the **H+/K+ ATPase pump**. * **D-cells:** These are the source of Somatostatin in the stomach; they act as the "universal brake" of the GI tract.

Q: All of the following are true about saccharolytic fermentation, EXCEPT:

SCFAs inhibit the growth of intestinal epithelial cells. ### Explanation **Saccharolytic fermentation** is the process by which anaerobic bacteria in the colon break down undigested carbohydrates (like dietary fiber and resistant starch) that have escaped digestion in the small intestine. **Why Option D is the correct answer (The Exception):** Short-chain fatty acids (SCFAs), particularly **butyric acid**, are the primary energy source for colonocytes (intestinal epithelial cells). Far from inhibiting growth, SCFAs are **trophic** to the intestinal mucosa. They promote cell proliferation, differentiation, and enhance the mucosal barrier. Butyrate also has anti-inflammatory and anti-neoplastic properties, helping to prevent colorectal cancer. **Analysis of Incorrect Options:** * **Option A & B:** These are fundamental definitions of the process. Saccharolytic fermentation is the metabolic **action of gut flora** (e.g., *Bifidobacterium*, *Lactobacillus*) on **undigested carbohydrates**. * **Option C:** The major end-products of this fermentation are indeed **Acetic acid (2C), Propionic acid (3C), and Butyric acid (4C)**. These are absorbed by the colonic mucosa and contribute to the host's daily energy requirements. **High-Yield Facts for NEET-PG:** * **Site:** Primarily occurs in the **proximal colon** (ascending colon). * **Gas Production:** Fermentation also produces gases like $CO_2$, $H_2$, and $CH_4$ (methane). * **pH Effect:** SCFAs lower the intraluminal pH, which inhibits the growth of pathogenic bacteria and promotes the absorption of minerals like calcium and magnesium. * **Clinical Correlation:** A lack of dietary fiber leads to decreased SCFA production, which is linked to mucosal atrophy and an increased risk of inflammatory bowel diseases.

Q: Migrating motor complex (MMC) occurs at the rate of and at an interval of?

5 cm/min, 90 min. ### Explanation The **Migrating Motor Complex (MMC)** is a distinct pattern of electromechanical activity observed in gastrointestinal smooth muscle during the **fasting state** (inter-digestive period). **1. Why Option B is Correct:** The MMC acts as a "housekeeper" of the small intestine, sweeping residual undigested food, secretions, and bacteria toward the colon. It moves at a velocity of approximately **5 cm/min** (slow and steady) and recurs at intervals of **90 to 120 minutes**. It originates in the stomach and travels down to the terminal ileum. **2. Why Other Options are Incorrect:** * **Options A & C:** These suggest a frequency of 5 minutes. The MMC is a long-cycle process; a 5-minute interval is far too frequent for a cycle that must traverse the entire small intestine. * **Options C & D:** These suggest a velocity in "cm/sec." A speed of 5 cm/sec or 90 cm/sec would be incredibly violent and rapid, more akin to a "peristaltic rush" seen in pathological states (like severe diarrhea), rather than the physiological cleaning mechanism of the MMC. **3. High-Yield Clinical Pearls for NEET-PG:** * **Hormonal Control:** The hormone **Motilin**, secreted by M cells in the duodenum and jejunum, is the primary initiator of the MMC. * **Feeding Effect:** Ingestion of food immediately terminates the MMC, replacing it with the "fed pattern" (segmentation and peristalsis). * **Phases:** The MMC has four phases; **Phase III** (the "activity front") is the most clinically significant, characterized by intense, rhythmic contractions. * **Clinical Correlation:** Erythromycin acts as a motilin agonist and can be used to stimulate GI motility by triggering MMC-like contractions. * **Function:** Absence of MMC can lead to **SIBO** (Small Intestinal Bacterial Overgrowth).

Q: Which of the following hormones decreases intestinal motility?

Glucagon. **Explanation:** Intestinal motility is regulated by a complex interplay of neural (enteric nervous system) and hormonal factors. **Why Glucagon is correct:** Glucagon, primarily secreted by the alpha cells of the pancreas, is known to be a potent **inhibitor of gastrointestinal motility**. It relaxes the smooth muscles of the stomach, small intestine, and colon. This inhibitory effect is so significant that intravenous glucagon is clinically used during radiological and endoscopic procedures (like ERCP or barium studies) to induce temporary intestinal "quietness" or atony, allowing for better visualization. **Why the other options are incorrect:** * **Cholecystokinin (CCK):** While CCK inhibits gastric emptying (to allow time for fat digestion), it actually **increases** intestinal motility (especially in the small bowel) and triggers the gastroileal reflex to move chyme along. * **Serotonin (5-HT):** Produced by enterochromaffin cells, serotonin is a major **stimulator** of the enteric nervous system. It initiates the peristaltic reflex; 5-HT3 and 5-HT4 receptors are key targets for drugs managing gut motility. * **Gastrin:** Primarily known for stimulating gastric acid secretion, gastrin also **increases** gastric and intestinal motility and stimulates the mass movement of feces (gastrocolic reflex). **High-Yield NEET-PG Pearls:** * **Motility Stimulators:** Gastrin, CCK, Motilin (initiates Migrating Motor Complex), Serotonin, and Substance P. * **Motility Inhibitors:** Glucagon, Secretin, Epinephrine (Sympathetic stimulation), and VIP (Vasoactive Intestinal Peptide - relaxes sphincters but inhibits general wall contraction). * **Clinical Fact:** Glucagon is the drug of choice for relaxing the lower esophageal sphincter in cases of food bolus impaction.

Q: Pepsinogen is activated by:

Low pH. **Explanation:** **1. Why Low pH is Correct:** Pepsinogen is a proenzyme (zymogen) secreted by the **Chief cells** (Peptic cells) of the stomach. It is biologically inactive to prevent the autodigestion of gastric mucosa. Activation occurs in the gastric lumen through two steps: * **Acid Activation:** When gastric pH falls below **3.5** (ideally between 1.8 and 2.5) due to HCl secreted by Parietal cells, a conformational change occurs. This causes the pepsinogen molecule to cleave itself, removing a protective amino acid mask to form active **Pepsin**. * **Autocatalysis:** Once a small amount of pepsin is formed, it further activates more pepsinogen molecules. **2. Why Other Options are Incorrect:** * **Enterokinase (A):** This enzyme is located on the duodenal brush border. Its specific role is to activate **Trypsinogen into Trypsin**. It does not act on gastric enzymes. * **Trypsin (C) & Chymotrypsin (D):** These are pancreatic proteases active in the alkaline environment of the small intestine. While Trypsin activates other pancreatic zymogens (like procarboxypeptidase), it has no role in the activation of gastric pepsinogen. **3. High-Yield Clinical Pearls for NEET-PG:** * **Optimal pH:** Pepsin is most active at pH **1.8–3.5**. It becomes irreversibly inactivated when the pH rises above **7.0** (e.g., when gastric contents enter the duodenum). * **Vagal Stimulation:** The Vagus nerve stimulates both HCl (Parietal cells) and Pepsinogen (Chief cells) secretion, ensuring both are present simultaneously for protein digestion. * **Achlorhydria:** In conditions like Pernicious Anemia (loss of parietal cells), the lack of HCl leads to a failure in pepsinogen activation, severely impairing gastric protein digestion.

Q: Which of the following prevents GERD?

Lower esophageal sphincter (LES) tone. **Explanation:** **Gastroesophageal Reflux Disease (GERD)** occurs when the retrograde flow of gastric contents into the esophagus causes symptoms or mucosal damage. The primary physiological barrier preventing this is the **Lower Esophageal Sphincter (LES) tone.** 1. **Why Option A is Correct:** The LES is a specialized smooth muscle zone at the distal esophagus. It maintains a high-pressure zone (resting tone of **10–30 mmHg**) that exceeds intragastric pressure. This tonic contraction, supported by the **crural diaphragm** (acting as an external sphincter) and the **Angle of His**, prevents the acidic gastric contents from entering the esophagus. A decrease in LES tone or transient LES relaxations (TLESRs) is the hallmark of GERD pathophysiology. 2. **Why Other Options are Incorrect:** * **Gastric and Esophageal Mucosa (B & C):** These are anatomical linings. While the esophageal mucosa has some protective mechanisms (bicarbonate secretion), it does not *prevent* reflux; it only attempts to resist damage *after* reflux has occurred. * **Acidic content of stomach (D):** This is the **causative agent** of the symptoms and mucosal injury in GERD, not a preventive factor. **High-Yield Clinical Pearls for NEET-PG:** * **The "Z-line":** The squamocolumnar junction where the esophageal epithelium changes to gastric epithelium. * **Hormonal Influence:** Gastrin increases LES tone, while Secretin, CCK, and Progesterone (as seen in pregnancy) decrease it. * **Barrett’s Esophagus:** A complication of chronic GERD where squamous epithelium undergoes **metaplasia** to specialized columnar epithelium (pre-malignant). * **Gold Standard Investigation:** 24-hour ambulatory pH monitoring.

Q: Which of the following regulators would MOST likely inhibit the lower esophageal sphincter in normal individuals?

Vasoactive intestinal polypeptide and nitric oxide. ### Explanation The Lower Esophageal Sphincter (LES) maintains a high-pressure zone to prevent gastroesophageal reflux. Its relaxation is a coordinated reflex mediated by the **myenteric plexus** during swallowing (receptive relaxation). **Why Option D is Correct:** The relaxation of the LES is primarily mediated by **inhibitory non-adrenergic, non-cholinergic (NANC) neurons**. These neurons release **Nitric Oxide (NO)** and **Vasoactive Intestinal Polypeptide (VIP)**. * **Nitric Oxide** acts via cGMP to decrease intracellular calcium, leading to smooth muscle relaxation. * **VIP** works through cAMP pathways to achieve a similar inhibitory effect. Together, they are the principal neurotransmitters responsible for the physiological opening of the LES. **Analysis of Incorrect Options:** * **Option A & C:** **Substance P** is an excitatory neurotransmitter in the GI tract. Along with **Acetylcholine (ACh)**, it promotes smooth muscle contraction and increases LES tone. * **Option B:** While this contains Nitric Oxide (inhibitory), the presence of Substance P (excitatory) makes the combination incorrect for overall inhibition. **NEET-PG High-Yield Pearls:** 1. **Achalasia Cardia:** A clinical condition caused by the failure of LES relaxation due to the loss of NO/VIP-producing inhibitory neurons in the myenteric (Auerbach’s) plexus. 2. **Hormonal Influence:** **Gastrin** increases LES tone (to prevent reflux during digestion), while **Secretin, Cholecystokinin (CCK), and Glucagon** generally decrease it. 3. **Pharmacology:** Calcium channel blockers and Nitrates are used to treat Achalasia because they mimic the inhibitory effect of NO on the LES.

Question 1

Which hormone influences the gastric phase of gastric acid secretion?

Accepted Answer

Gastrin

Answer

Secretin

Answer

Vasoactive intestinal peptide (VIP)

Answer

Gastric inhibitory peptide (GIP)

Question 2

What is the primary action of Nitric oxide (NO) in the gastrointestinal tract?

Accepted Answer

Gastrointestinal smooth muscle relaxation

Answer

Vasodilatation

Answer

Vasoconstriction

Answer

Gastrointestinal slow smooth muscle contraction

Question 3

Gastrin is produced by:

Accepted Answer

All

Answer

Pancreas

Answer

Gastric antral cells

Answer

Pituitary

Question 4

Which of the following stimulates HCl secretion?

Accepted Answer

Somatostatin

Answer

Secretin

Answer

Histamine

Answer

Gastrin

Question 5

All of the following are true about saccharolytic fermentation, EXCEPT:

Accepted Answer

SCFAs inhibit the growth of intestinal epithelial cells

Answer

Undigested carbohydrate is converted into short-chain fatty acids (SCFAs)

Answer

Action of gut flora

Answer

Acetic acid, butyric acid, and propionic acid are its products

Question 6

Migrating motor complex (MMC) occurs at the rate of and at an interval of?

Accepted Answer

5 cm/min, 90 min

Answer

90 cm/min, 5 min

Answer

90 cm/sec, 5 min

Answer

5 cm/sec, 90 min

Question 7

Which of the following hormones decreases intestinal motility?

Accepted Answer

Glucagon

Answer

Cholecystokinin (CCK)

Answer

Serotonin

Answer

Gastrin

Question 8

Pepsinogen is activated by:

Accepted Answer

Low pH

Answer

Enterokinase

Answer

Trypsin

Answer

Chymotrypsin

Question 9

Which of the following prevents GERD?

Accepted Answer

Lower esophageal sphincter (LES) tone

Answer

Gastric mucosa

Answer

Esophageal mucosa

Answer

Acidic content of stomach

Question 10

Which of the following regulators would MOST likely inhibit the lower esophageal sphincter in normal individuals?

Accepted Answer

Vasoactive intestinal polypeptide and nitric oxide

Answer

Acetylcholine and substance P

Answer

Substance P and nitric oxide

Answer

Substance P only

Gastrointestinal System — MCQs

Gastrointestinal System — MCQs

On this page

Practice by Chapter

Want unlimited practice?